

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.25954711 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.25954711 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.91073894 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.91073894 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.40102315 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.11496223 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.90059590 |
| 8 | polyketide metabolic process (GO:0030638) | 5.85050366 |
| 9 | doxorubicin metabolic process (GO:0044598) | 5.85050366 |
| 10 | daunorubicin metabolic process (GO:0044597) | 5.85050366 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.62005604 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.62005604 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.62005604 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.60426515 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.54193767 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.44054106 |
| 17 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.34811345 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.34652009 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.29258291 |
| 20 | cysteine metabolic process (GO:0006534) | 5.24606575 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.21142395 |
| 22 | urea metabolic process (GO:0019627) | 5.18404972 |
| 23 | urea cycle (GO:0000050) | 5.18404972 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.09902842 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 5.05317028 |
| 26 | protein carboxylation (GO:0018214) | 5.03822636 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.03822636 |
| 28 | primary alcohol catabolic process (GO:0034310) | 4.92301512 |
| 29 | bile acid metabolic process (GO:0008206) | 4.89187887 |
| 30 | epoxygenase P450 pathway (GO:0019373) | 4.80112283 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.79510200 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.76078733 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.73259868 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.67887270 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 4.67092878 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.64529879 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.63599798 |
| 38 | lysine metabolic process (GO:0006553) | 4.61979534 |
| 39 | lysine catabolic process (GO:0006554) | 4.61979534 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.59722530 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.59629792 |
| 42 | regulation of protein activation cascade (GO:2000257) | 4.58962736 |
| 43 | exogenous drug catabolic process (GO:0042738) | 4.58474056 |
| 44 | homocysteine metabolic process (GO:0050667) | 4.56453390 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.54247310 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.54242823 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.54242823 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.54242823 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.52203680 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.52203680 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 4.50266120 |
| 52 | progesterone metabolic process (GO:0042448) | 4.49380965 |
| 53 | phospholipid efflux (GO:0033700) | 4.45145830 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.38152120 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.36277849 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.36277849 |
| 57 | ethanol metabolic process (GO:0006067) | 4.31345804 |
| 58 | regulation of complement activation (GO:0030449) | 4.28142985 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.25019513 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 4.22197757 |
| 61 | drug catabolic process (GO:0042737) | 4.18935070 |
| 62 | cholesterol efflux (GO:0033344) | 4.14501653 |
| 63 | androgen biosynthetic process (GO:0006702) | 4.13663698 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 4.09620476 |
| 65 | cellular glucuronidation (GO:0052695) | 4.09308132 |
| 66 | glutamate metabolic process (GO:0006536) | 4.07630024 |
| 67 | ethanol oxidation (GO:0006069) | 4.06017013 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.03792829 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.02387155 |
| 70 | glucocorticoid biosynthetic process (GO:0006704) | 3.99855301 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 3.98548139 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 3.96508890 |
| 73 | omega-hydroxylase P450 pathway (GO:0097267) | 3.91736462 |
| 74 | short-chain fatty acid metabolic process (GO:0046459) | 3.89512917 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.89430406 |
| 76 | ketone body metabolic process (GO:1902224) | 3.89330833 |
| 77 | glycine metabolic process (GO:0006544) | 3.87450205 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 3.87418084 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 3.84468556 |
| 80 | amine catabolic process (GO:0009310) | 3.84468556 |
| 81 | positive regulation of lipid catabolic process (GO:0050996) | 3.83339651 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.81879109 |
| 83 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.81682256 |
| 84 | regulation of cholesterol homeostasis (GO:2000188) | 3.79843999 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 3.79360089 |
| 86 | desmosome organization (GO:0002934) | 3.78627984 |
| 87 | drug transmembrane transport (GO:0006855) | 3.74542949 |
| 88 | phospholipid homeostasis (GO:0055091) | 3.73259236 |
| 89 | C21-steroid hormone metabolic process (GO:0008207) | 3.72894319 |
| 90 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72106479 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72106479 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.71386811 |
| 93 | organic acid catabolic process (GO:0016054) | 3.70044050 |
| 94 | carboxylic acid catabolic process (GO:0046395) | 3.70044050 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.67193640 |
| 96 | uronic acid metabolic process (GO:0006063) | 3.67193640 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.66404494 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.66014682 |
| 99 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.64795257 |
| 100 | fibrinolysis (GO:0042730) | 3.64102205 |
| 101 | serine family amino acid biosynthetic process (GO:0009070) | 3.63866370 |
| 102 | arginine metabolic process (GO:0006525) | 3.63552084 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 3.62569576 |
| 104 | sterol homeostasis (GO:0055092) | 3.60982603 |
| 105 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60379490 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60208851 |
| 107 | negative regulation of lipase activity (GO:0060192) | 3.60148920 |
| 108 | fatty acid oxidation (GO:0019395) | 3.59668442 |
| 109 | heme transport (GO:0015886) | 3.59611796 |
| 110 | monocarboxylic acid catabolic process (GO:0072329) | 3.58985661 |
| 111 | low-density lipoprotein particle clearance (GO:0034383) | 3.55100682 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.53603576 |
| 113 | lipid oxidation (GO:0034440) | 3.52777688 |
| 114 | phenylpropanoid metabolic process (GO:0009698) | 3.51979447 |
| 115 | drug metabolic process (GO:0017144) | 3.51720156 |
| 116 | flavonoid metabolic process (GO:0009812) | 3.51308036 |
| 117 | blood coagulation, intrinsic pathway (GO:0007597) | 3.51240746 |
| 118 | intestinal cholesterol absorption (GO:0030299) | 3.50472789 |
| 119 | glycoside metabolic process (GO:0016137) | 3.50232856 |
| 120 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.43047081 |
| 121 | negative regulation of protein activation cascade (GO:2000258) | 3.42904645 |
| 122 | retinal metabolic process (GO:0042574) | 3.42765893 |
| 123 | hormone catabolic process (GO:0042447) | 3.29914280 |
| 124 | negative regulation of blood coagulation (GO:0030195) | 3.25681445 |
| 125 | negative regulation of hemostasis (GO:1900047) | 3.25681445 |
| 126 | * primary alcohol metabolic process (GO:0034308) | 3.25673095 |
| 127 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.25280100 |
| 128 | glucocorticoid metabolic process (GO:0008211) | 3.23768648 |
| 129 | carnitine metabolic process (GO:0009437) | 3.22425192 |
| 130 | response to mercury ion (GO:0046689) | 3.22357742 |
| 131 | androgen metabolic process (GO:0008209) | 3.17100141 |
| 132 | gap junction assembly (GO:0016264) | 3.12168640 |
| 133 | intestinal absorption (GO:0050892) | 3.10004356 |
| 134 | regulation of cholesterol metabolic process (GO:0090181) | 3.07148130 |
| 135 | negative regulation of wound healing (GO:0061045) | 3.06219421 |
| 136 | protein activation cascade (GO:0072376) | 3.04648177 |
| 137 | negative regulation of coagulation (GO:0050819) | 3.04584162 |
| 138 | regulation of apoptotic cell clearance (GO:2000425) | 2.99601156 |
| 139 | biotin metabolic process (GO:0006768) | 2.99223393 |
| 140 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.96696072 |
| 141 | complement activation, classical pathway (GO:0006958) | 2.95901912 |
| 142 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.93974178 |
| 143 | regulation of plasminogen activation (GO:0010755) | 2.93593404 |
| 144 | negative regulation of complement activation (GO:0045916) | 2.91887922 |
| 145 | response to phenylpropanoid (GO:0080184) | 2.91593549 |
| 146 | complement activation (GO:0006956) | 2.91370562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.88381909 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.76256959 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.23303539 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.13359430 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.08654657 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.85700726 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.72923098 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.42152593 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86381484 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.42765681 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.63437979 |
| 12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.25183403 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03260996 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00011838 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9372307 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89606099 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84925006 |
| 18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.73412814 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64347584 |
| 20 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.53671110 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.53191582 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50511915 |
| 23 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44373555 |
| 24 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40880922 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40525422 |
| 26 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40010331 |
| 27 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.39405369 |
| 28 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37322958 |
| 29 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36579646 |
| 30 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36579646 |
| 31 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32066661 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29445734 |
| 33 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26915975 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26246494 |
| 35 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17124191 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14837540 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13608887 |
| 38 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12290665 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11301575 |
| 40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10536451 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09478122 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08939810 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07137961 |
| 44 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04753823 |
| 45 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03817714 |
| 46 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03435216 |
| 47 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.03014403 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02199491 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01680641 |
| 50 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00409848 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00093070 |
| 52 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98993682 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97194346 |
| 54 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.96299438 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95550081 |
| 56 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92181561 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91929919 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91754680 |
| 59 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91019186 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90917820 |
| 61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.90571051 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89518080 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89518080 |
| 64 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89127422 |
| 65 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87472099 |
| 66 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.85935430 |
| 67 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85807436 |
| 68 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.83881621 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.83520329 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83498289 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82050271 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81489445 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81422975 |
| 74 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.81028190 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.80809777 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79483564 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79192226 |
| 78 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78063509 |
| 79 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77975128 |
| 80 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77896597 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77825144 |
| 82 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 0.77505072 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77364100 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77115734 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75922790 |
| 86 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.75735573 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.75686174 |
| 88 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75392251 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75327025 |
| 90 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.75318173 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73824058 |
| 92 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.72794479 |
| 93 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70291485 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69683828 |
| 95 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.68764207 |
| 96 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.67290094 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65036832 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64715051 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63166155 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62014240 |
| 101 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.61536879 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60591995 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.60465490 |
| 104 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59629036 |
| 105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.59585254 |
| 106 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59441334 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58079904 |
| 108 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58069533 |
| 109 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57590174 |
| 110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57349882 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.57073046 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55234495 |
| 113 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.55148546 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54808069 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52735431 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.52462516 |
| 117 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52351139 |
| 118 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52035486 |
| 119 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51943196 |
| 120 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.51572753 |
| 121 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50466499 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.50434939 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.49969920 |
| 124 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49747034 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.49268141 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.48210651 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47396966 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.46697607 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46239164 |
| 130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.46108220 |
| 131 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.45496326 |
| 132 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.45452112 |
| 133 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.45277841 |
| 134 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45240841 |
| 135 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.45167053 |
| 136 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.44812191 |
| 137 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.44812191 |
| 138 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.44141993 |
| 139 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.43937020 |
| 140 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43895812 |
| 141 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.43183274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.27234698 |
| 2 | MP0005360_urolithiasis | 7.20030521 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.13933177 |
| 4 | MP0005365_abnormal_bile_salt | 6.06362338 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.16372770 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.93244902 |
| 7 | MP0003252_abnormal_bile_duct | 3.93186268 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.44963108 |
| 9 | MP0009840_abnormal_foam_cell | 3.23702510 |
| 10 | MP0005083_abnormal_biliary_tract | 3.02165024 |
| 11 | MP0003195_calcinosis | 2.84630723 |
| 12 | MP0005332_abnormal_amino_acid | 2.80496897 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.72566768 |
| 14 | MP0003941_abnormal_skin_development | 2.64797576 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.27876692 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.24635697 |
| 17 | MP0000566_synostosis | 2.19785566 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.13668493 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.12753113 |
| 20 | MP0000609_abnormal_liver_physiology | 2.11225977 |
| 21 | MP0003868_abnormal_feces_composition | 1.83374872 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.77549812 |
| 23 | MP0005451_abnormal_body_composition | 1.58269919 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55791935 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.53319743 |
| 26 | MP0001764_abnormal_homeostasis | 1.48689653 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.45527569 |
| 28 | MP0003890_abnormal_embryonic-extraembry | 1.42144913 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.36639793 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.27178715 |
| 31 | MP0004272_abnormal_basement_membrane | 1.26473227 |
| 32 | MP0005501_abnormal_skin_physiology | 1.26145876 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.21767692 |
| 34 | MP0000604_amyloidosis | 1.20372628 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.19920130 |
| 36 | MP0003186_abnormal_redox_activity | 1.18833995 |
| 37 | MP0009697_abnormal_copulation | 1.16738962 |
| 38 | MP0005409_darkened_coat_color | 1.12700896 |
| 39 | MP0000598_abnormal_liver_morphology | 1.11719109 |
| 40 | MP0002254_reproductive_system_inflammat | 1.11374783 |
| 41 | MP0004233_abnormal_muscle_weight | 1.11337512 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.09538317 |
| 43 | MP0003011_delayed_dark_adaptation | 1.08913902 |
| 44 | MP0010678_abnormal_skin_adnexa | 1.08187113 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.07706269 |
| 46 | MP0009764_decreased_sensitivity_to | 1.06290307 |
| 47 | MP0005647_abnormal_sex_gland | 1.03800657 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 1.02424837 |
| 49 | MP0002098_abnormal_vibrissa_morphology | 1.01733317 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 0.94496235 |
| 51 | MP0001216_abnormal_epidermal_layer | 0.94296201 |
| 52 | MP0005275_abnormal_skin_tensile | 0.93781264 |
| 53 | MP0001915_intracranial_hemorrhage | 0.93567093 |
| 54 | MP0009763_increased_sensitivity_to | 0.93563834 |
| 55 | MP0009379_abnormal_foot_pigmentation | 0.93009464 |
| 56 | MP0005408_hypopigmentation | 0.91317389 |
| 57 | MP0009642_abnormal_blood_homeostasis | 0.86979196 |
| 58 | MP0002876_abnormal_thyroid_physiology | 0.86798101 |
| 59 | MP0000537_abnormal_urethra_morphology | 0.86415630 |
| 60 | MP0008469_abnormal_protein_level | 0.85288918 |
| 61 | MP0000762_abnormal_tongue_morphology | 0.84706573 |
| 62 | MP0010368_abnormal_lymphatic_system | 0.84575505 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.84198642 |
| 64 | MP0001756_abnormal_urination | 0.83546379 |
| 65 | MP0003329_amyloid_beta_deposits | 0.82912189 |
| 66 | MP0002060_abnormal_skin_morphology | 0.79093047 |
| 67 | MP0005257_abnormal_intraocular_pressure | 0.79021283 |
| 68 | MP0005375_adipose_tissue_phenotype | 0.78453455 |
| 69 | MP0005220_abnormal_exocrine_pancreas | 0.78318327 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 0.78145536 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.77525896 |
| 72 | MP0003690_abnormal_glial_cell | 0.77504966 |
| 73 | MP0005076_abnormal_cell_differentiation | 0.76339193 |
| 74 | MP0002896_abnormal_bone_mineralization | 0.75619708 |
| 75 | MP0004130_abnormal_muscle_cell | 0.74280332 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 0.73425295 |
| 77 | MP0005670_abnormal_white_adipose | 0.72753035 |
| 78 | MP0000647_abnormal_sebaceous_gland | 0.72642731 |
| 79 | MP0005023_abnormal_wound_healing | 0.71995433 |
| 80 | MP0005376_homeostasis/metabolism_phenot | 0.71573548 |
| 81 | MP0005334_abnormal_fat_pad | 0.70892950 |
| 82 | MP0005330_cardiomyopathy | 0.70503574 |
| 83 | MP0002971_abnormal_brown_adipose | 0.70390816 |
| 84 | MP0001661_extended_life_span | 0.69690234 |
| 85 | MP0002697_abnormal_eye_size | 0.69366184 |
| 86 | MP0005535_abnormal_body_temperature | 0.69259976 |
| 87 | MP0000467_abnormal_esophagus_morphology | 0.68657049 |
| 88 | MP0004043_abnormal_pH_regulation | 0.68422517 |
| 89 | MP0000377_abnormal_hair_follicle | 0.67703172 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.67421028 |
| 91 | MP0002269_muscular_atrophy | 0.66805737 |
| 92 | MP0005187_abnormal_penis_morphology | 0.66664037 |
| 93 | MP0004858_abnormal_nervous_system | 0.64937606 |
| 94 | MP0010030_abnormal_orbit_morphology | 0.64357698 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.63761183 |
| 96 | MP0000462_abnormal_digestive_system | 0.62665296 |
| 97 | MP0008004_abnormal_stomach_pH | 0.62509526 |
| 98 | MP0005058_abnormal_lysosome_morphology | 0.62366392 |
| 99 | MP0003879_abnormal_hair_cell | 0.60211730 |
| 100 | MP0000747_muscle_weakness | 0.60069336 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.59789131 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.59458409 |
| 103 | MP0000383_abnormal_hair_follicle | 0.58380763 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.58163900 |
| 105 | MP0000751_myopathy | 0.58133913 |
| 106 | MP0005448_abnormal_energy_balance | 0.57521846 |
| 107 | MP0002928_abnormal_bile_duct | 0.57447513 |
| 108 | MP0009672_abnormal_birth_weight | 0.56825952 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.54700605 |
| 110 | MP0005266_abnormal_metabolism | 0.54222757 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.53719821 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.53109360 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.52089707 |
| 114 | MP0003075_altered_response_to | 0.48812638 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.47863831 |
| 116 | MP0009053_abnormal_anal_canal | 0.47455013 |
| 117 | MP0002168_other_aberrant_phenotype | 0.47411390 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 0.47392483 |
| 119 | MP0008874_decreased_physiological_sensi | 0.46714879 |
| 120 | MP0005395_other_phenotype | 0.46292758 |
| 121 | MP0003724_increased_susceptibility_to | 0.45971070 |
| 122 | MP0003953_abnormal_hormone_level | 0.45056919 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.44383302 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.43011565 |
| 125 | MP0002796_impaired_skin_barrier | 0.42403713 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.42374637 |
| 127 | MP0005166_decreased_susceptibility_to | 0.41023149 |
| 128 | MP0008873_increased_physiological_sensi | 0.40692196 |
| 129 | MP0003436_decreased_susceptibility_to | 0.40189561 |
| 130 | MP0006082_CNS_inflammation | 0.38868981 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.38099105 |
| 132 | MP0005248_abnormal_Harderian_gland | 0.37825658 |
| 133 | MP0000249_abnormal_blood_vessel | 0.33639075 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.33248997 |
| 135 | MP0001243_abnormal_dermal_layer | 0.32637714 |
| 136 | MP0002822_catalepsy | 0.32211838 |
| 137 | MP0002090_abnormal_vision | 0.31891534 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.31166847 |
| 139 | MP0001881_abnormal_mammary_gland | 0.30886593 |
| 140 | MP0008872_abnormal_physiological_respon | 0.29896449 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.29715613 |
| 142 | MP0004883_abnormal_blood_vessel | 0.28926025 |
| 143 | MP0000579_abnormal_nail_morphology | 0.28725391 |
| 144 | MP0001944_abnormal_pancreas_morphology | 0.28621410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.05716890 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.98339261 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.92485075 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.28298187 |
| 5 | Xanthomatosis (HP:0000991) | 6.17611408 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.04456686 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.89797014 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.31556510 |
| 9 | Hyperammonemia (HP:0001987) | 4.52849057 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.51390944 |
| 11 | Complement deficiency (HP:0004431) | 4.49923238 |
| 12 | Epidermoid cyst (HP:0200040) | 4.41318867 |
| 13 | Joint hemorrhage (HP:0005261) | 4.40177885 |
| 14 | Ketosis (HP:0001946) | 4.39115445 |
| 15 | Hyperglycinemia (HP:0002154) | 4.23529682 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.21515881 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16623735 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15277931 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10689558 |
| 20 | Fat malabsorption (HP:0002630) | 4.07175552 |
| 21 | Hypoglycemic coma (HP:0001325) | 4.05938119 |
| 22 | Hyperglycinuria (HP:0003108) | 4.02351261 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97446753 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.97100287 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.97100287 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.94293898 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.88882495 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.84868374 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.61849426 |
| 30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.54982857 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.53814482 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.47186018 |
| 33 | Ketoacidosis (HP:0001993) | 3.38436957 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.26992387 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.25651940 |
| 36 | Abnormality of complement system (HP:0005339) | 3.22422245 |
| 37 | Right ventricular cardiomyopathy (HP:0011663) | 3.20376126 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11040616 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 3.03734954 |
| 40 | Delayed CNS myelination (HP:0002188) | 3.00664116 |
| 41 | Steatorrhea (HP:0002570) | 2.98397137 |
| 42 | Renal salt wasting (HP:0000127) | 2.97453062 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.89795198 |
| 44 | Nephritis (HP:0000123) | 2.88886366 |
| 45 | Gout (HP:0001997) | 2.85011193 |
| 46 | Metabolic acidosis (HP:0001942) | 2.84220272 |
| 47 | Myocardial infarction (HP:0001658) | 2.82882770 |
| 48 | Skin nodule (HP:0200036) | 2.82188215 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.79439873 |
| 50 | Vascular calcification (HP:0004934) | 2.78738760 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.74626442 |
| 52 | Hypoglycemic seizures (HP:0002173) | 2.73337671 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66160598 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.66160598 |
| 55 | Spastic diplegia (HP:0001264) | 2.53870156 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.50950771 |
| 57 | Cardiovascular calcification (HP:0011915) | 2.50852287 |
| 58 | Lethargy (HP:0001254) | 2.50828331 |
| 59 | Flat acetabular roof (HP:0003180) | 2.50825367 |
| 60 | Malnutrition (HP:0004395) | 2.48095015 |
| 61 | Spontaneous abortion (HP:0005268) | 2.45525999 |
| 62 | Acanthocytosis (HP:0001927) | 2.45070612 |
| 63 | Bifid scrotum (HP:0000048) | 2.43259077 |
| 64 | Mitral stenosis (HP:0001718) | 2.42854809 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.41687432 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.40938276 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.40138300 |
| 68 | Irritability (HP:0000737) | 2.37854616 |
| 69 | Esophageal varix (HP:0002040) | 2.34343626 |
| 70 | Hyperaldosteronism (HP:0000859) | 2.33361622 |
| 71 | Glomerulonephritis (HP:0000099) | 2.30980127 |
| 72 | Late onset (HP:0003584) | 2.30782061 |
| 73 | Cholelithiasis (HP:0001081) | 2.30227191 |
| 74 | Abnormal sex determination (HP:0012244) | 2.28801853 |
| 75 | Sex reversal (HP:0012245) | 2.28801853 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.27863240 |
| 77 | Osteomalacia (HP:0002749) | 2.27394272 |
| 78 | Cholecystitis (HP:0001082) | 2.27387559 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.27387559 |
| 80 | Abnormality of carpal bone ossification (HP:0006257) | 2.25860490 |
| 81 | Pancreatitis (HP:0001733) | 2.20306633 |
| 82 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19347178 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 2.17948931 |
| 84 | Hydroxyprolinuria (HP:0003080) | 2.17948931 |
| 85 | Neonatal onset (HP:0003623) | 2.16370285 |
| 86 | Enlarged kidneys (HP:0000105) | 2.15048703 |
| 87 | Alkalosis (HP:0001948) | 2.14722656 |
| 88 | Amyloidosis (HP:0011034) | 2.14505059 |
| 89 | Cerebral edema (HP:0002181) | 2.12708736 |
| 90 | Brushfield spots (HP:0001088) | 2.12567811 |
| 91 | Abnormal tarsal ossification (HP:0008369) | 2.12268148 |
| 92 | Neurofibrillary tangles (HP:0002185) | 2.10868641 |
| 93 | Rickets (HP:0002748) | 2.10026565 |
| 94 | Vomiting (HP:0002013) | 2.09442292 |
| 95 | Back pain (HP:0003418) | 2.08360150 |
| 96 | Menorrhagia (HP:0000132) | 2.06590883 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.03638446 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03605417 |
| 99 | Renal cortical cysts (HP:0000803) | 2.02071653 |
| 100 | Hemorrhage of the eye (HP:0011885) | 1.99911879 |
| 101 | Opisthotonus (HP:0002179) | 1.99731509 |
| 102 | Abnormality of the gallbladder (HP:0005264) | 1.98239403 |
| 103 | Abnormality of urine glucose concentration (HP:0011016) | 1.97532055 |
| 104 | Glycosuria (HP:0003076) | 1.97532055 |
| 105 | Gingival bleeding (HP:0000225) | 1.97314683 |
| 106 | Increased purine levels (HP:0004368) | 1.97220353 |
| 107 | Hyperuricemia (HP:0002149) | 1.97220353 |
| 108 | Hyperactive renin-angiotensin system (HP:0000841) | 1.96614644 |
| 109 | Abnormality of the Achilles tendon (HP:0005109) | 1.94178371 |
| 110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93012954 |
| 111 | Abnormality of the gastric mucosa (HP:0004295) | 1.91136941 |
| 112 | Short nail (HP:0001799) | 1.91112358 |
| 113 | Abnormal cartilage morphology (HP:0002763) | 1.91070601 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.90078170 |
| 115 | Neonatal death (HP:0003811) | 1.88933817 |
| 116 | Symptomatic seizures (HP:0011145) | 1.87339907 |
| 117 | Abnormality of glycolysis (HP:0004366) | 1.86001728 |
| 118 | Advanced eruption of teeth (HP:0006288) | 1.85217221 |
| 119 | Hyperglycemia (HP:0003074) | 1.84625762 |
| 120 | Increased serum pyruvate (HP:0003542) | 1.84329914 |
| 121 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83177579 |
| 122 | Thrombophlebitis (HP:0004418) | 1.82292575 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.80644519 |
| 124 | Cerebral inclusion bodies (HP:0100314) | 1.79879531 |
| 125 | Palmoplantar hyperkeratosis (HP:0000972) | 1.79386192 |
| 126 | Abnormality of secondary sexual hair (HP:0009888) | 1.78526947 |
| 127 | Abnormality of the axillary hair (HP:0100134) | 1.78526947 |
| 128 | Acanthosis nigricans (HP:0000956) | 1.77399583 |
| 129 | Atrioventricular block (HP:0001678) | 1.75917205 |
| 130 | Aplasia involving bones of the extremities (HP:0009825) | 1.74026502 |
| 131 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.74026502 |
| 132 | Aplasia of the phalanges of the hand (HP:0009802) | 1.74026502 |
| 133 | Palmar hyperkeratosis (HP:0010765) | 1.71309813 |
| 134 | Tetraparesis (HP:0002273) | 1.69768810 |
| 135 | Exercise-induced myalgia (HP:0003738) | 1.66631948 |
| 136 | Abnormal ossification of hand bones (HP:0005921) | 1.65947110 |
| 137 | Absent eyelashes (HP:0000561) | 1.65843457 |
| 138 | Bronchomalacia (HP:0002780) | 1.64979413 |
| 139 | Abnormal hand bone ossification (HP:0010660) | 1.61874621 |
| 140 | Elevated alkaline phosphatase (HP:0003155) | 1.61168736 |
| 141 | Plantar hyperkeratosis (HP:0007556) | 1.60934153 |
| 142 | Vertebral arch anomaly (HP:0008438) | 1.59288631 |
| 143 | Pterygium (HP:0001059) | 1.57660623 |
| 144 | Abnormality of the dental root (HP:0006486) | 1.56415588 |
| 145 | Taurodontia (HP:0000679) | 1.56415588 |
| 146 | Abnormality of permanent molar morphology (HP:0011071) | 1.56415588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.21777324 |
| 2 | SIK1 | 4.29099389 |
| 3 | ERN1 | 4.12631176 |
| 4 | FGFR4 | 3.86276632 |
| 5 | EPHA2 | 3.48947303 |
| 6 | TAOK3 | 2.99992072 |
| 7 | INSRR | 2.97325184 |
| 8 | LATS2 | 2.52489774 |
| 9 | PKN2 | 2.22267407 |
| 10 | MST1R | 2.11862613 |
| 11 | ERBB4 | 2.09791717 |
| 12 | LMTK2 | 2.08946740 |
| 13 | PBK | 2.07333229 |
| 14 | FRK | 2.06610771 |
| 15 | EEF2K | 2.06559100 |
| 16 | TRIB3 | 2.03418809 |
| 17 | MAP2K4 | 1.93303469 |
| 18 | PTK6 | 1.84718314 |
| 19 | PIK3CG | 1.74737553 |
| 20 | LATS1 | 1.70175731 |
| 21 | NEK1 | 1.66704760 |
| 22 | FLT3 | 1.60570391 |
| 23 | FGFR2 | 1.59933842 |
| 24 | EPHB1 | 1.58758741 |
| 25 | TYK2 | 1.49153194 |
| 26 | DAPK2 | 1.44270018 |
| 27 | SCYL2 | 1.44231371 |
| 28 | PAK4 | 1.31603577 |
| 29 | MAPK11 | 1.28732656 |
| 30 | MAP3K12 | 1.25153811 |
| 31 | TESK1 | 1.24299811 |
| 32 | MAP3K9 | 1.23455574 |
| 33 | PRPF4B | 1.21530579 |
| 34 | MET | 1.21505244 |
| 35 | NEK9 | 1.15959808 |
| 36 | JAK2 | 1.15891462 |
| 37 | MAP3K7 | 1.12514302 |
| 38 | JAK1 | 1.12193578 |
| 39 | DDR2 | 1.10995844 |
| 40 | EPHB2 | 1.09481341 |
| 41 | MAPK15 | 1.08307342 |
| 42 | ABL2 | 1.06732295 |
| 43 | RIPK1 | 1.05524579 |
| 44 | MAP2K3 | 1.05419143 |
| 45 | PRKD3 | 1.04041862 |
| 46 | PRKAA2 | 1.03610788 |
| 47 | WNK4 | 1.01491801 |
| 48 | MAP3K3 | 0.99860021 |
| 49 | TBK1 | 0.99598302 |
| 50 | MAP3K10 | 0.99352362 |
| 51 | TTK | 0.98052815 |
| 52 | ERBB3 | 0.97896644 |
| 53 | MAPKAPK3 | 0.95831713 |
| 54 | MAP3K2 | 0.95229592 |
| 55 | BCR | 0.94268806 |
| 56 | KDR | 0.93919428 |
| 57 | PTK2 | 0.93334617 |
| 58 | FGFR1 | 0.93095601 |
| 59 | MAP3K6 | 0.91662539 |
| 60 | MAP3K14 | 0.89756821 |
| 61 | CAMK1D | 0.86765616 |
| 62 | GRK6 | 0.84171588 |
| 63 | CSK | 0.83363196 |
| 64 | OBSCN | 0.83344245 |
| 65 | GSK3A | 0.83061393 |
| 66 | TGFBR2 | 0.81781228 |
| 67 | SGK3 | 0.80472852 |
| 68 | OXSR1 | 0.79356912 |
| 69 | EPHA3 | 0.79145753 |
| 70 | SMG1 | 0.79076970 |
| 71 | STK24 | 0.78443673 |
| 72 | PRKCZ | 0.78356111 |
| 73 | BRSK2 | 0.77776817 |
| 74 | STK38 | 0.77257273 |
| 75 | TIE1 | 0.76277883 |
| 76 | CDK12 | 0.75983916 |
| 77 | AKT2 | 0.75959127 |
| 78 | ERBB2 | 0.74575749 |
| 79 | IRAK3 | 0.74428095 |
| 80 | ARAF | 0.73132091 |
| 81 | STK38L | 0.72541760 |
| 82 | NTRK1 | 0.72533260 |
| 83 | PINK1 | 0.70402750 |
| 84 | STK39 | 0.70325018 |
| 85 | PDPK1 | 0.69762121 |
| 86 | CDK6 | 0.69525839 |
| 87 | MAPK4 | 0.68725453 |
| 88 | RET | 0.67683502 |
| 89 | TTN | 0.67386311 |
| 90 | DYRK1B | 0.66268662 |
| 91 | PRKACG | 0.66081888 |
| 92 | MST4 | 0.65842841 |
| 93 | FER | 0.64823419 |
| 94 | SGK223 | 0.64713526 |
| 95 | SGK494 | 0.64713526 |
| 96 | CAMK2G | 0.61414147 |
| 97 | PIK3CA | 0.60435296 |
| 98 | PRKAA1 | 0.60365555 |
| 99 | LIMK1 | 0.60337027 |
| 100 | YES1 | 0.59598799 |
| 101 | MAP2K1 | 0.58396167 |
| 102 | FGFR3 | 0.58245509 |
| 103 | EIF2AK1 | 0.58076209 |
| 104 | PAK3 | 0.57934874 |
| 105 | PRKCQ | 0.55216774 |
| 106 | EIF2AK3 | 0.55035295 |
| 107 | CDK9 | 0.54934552 |
| 108 | DMPK | 0.54882105 |
| 109 | SGK2 | 0.54271000 |
| 110 | MAP2K6 | 0.54262705 |
| 111 | MAP2K2 | 0.54117702 |
| 112 | CAMK1G | 0.53397175 |
| 113 | MAPK12 | 0.53231665 |
| 114 | PDGFRA | 0.53186420 |
| 115 | CSNK1G1 | 0.51333547 |
| 116 | AKT3 | 0.51278409 |
| 117 | MELK | 0.51038311 |
| 118 | MAP3K1 | 0.50396610 |
| 119 | PDK3 | 0.48481979 |
| 120 | PDK4 | 0.48481979 |
| 121 | EPHA4 | 0.47560568 |
| 122 | PHKG1 | 0.47394778 |
| 123 | PHKG2 | 0.47394778 |
| 124 | PIM2 | 0.46702691 |
| 125 | TAOK2 | 0.46676805 |
| 126 | CSF1R | 0.45570143 |
| 127 | KSR2 | 0.45471112 |
| 128 | MAP3K11 | 0.45092092 |
| 129 | PDK1 | 0.44545136 |
| 130 | IGF1R | 0.43302431 |
| 131 | NLK | 0.42314678 |
| 132 | LRRK2 | 0.41476891 |
| 133 | NEK6 | 0.41160579 |
| 134 | MAPK10 | 0.40858541 |
| 135 | CDK7 | 0.40669738 |
| 136 | ITK | 0.39554159 |
| 137 | PDGFRB | 0.39349246 |
| 138 | CSNK1G2 | 0.38890982 |
| 139 | IKBKE | 0.38591653 |
| 140 | MAPK7 | 0.38122220 |
| 141 | ACVR1B | 0.38034739 |
| 142 | STK3 | 0.37848143 |
| 143 | ICK | 0.37780642 |
| 144 | BMX | 0.37164556 |
| 145 | EGFR | 0.35469384 |
| 146 | MAP3K13 | 0.34382275 |
| 147 | CSNK1A1L | 0.34260557 |
| 148 | MTOR | 0.33941000 |
| 149 | PRKCH | 0.32206977 |
| 150 | GRK1 | 0.32098272 |
| 151 | MYLK | 0.31646952 |
| 152 | PDK2 | 0.30879307 |
| 153 | CSNK1G3 | 0.30340241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.24998470 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49317915 |
| 3 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28681210 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17189238 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.99960125 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.87012472 |
| 7 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62634618 |
| 8 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.59223986 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56207741 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46554045 |
| 11 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46399340 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36879245 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33940552 |
| 14 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19842533 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.17423443 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.15239169 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09243530 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01394698 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.98501911 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93117588 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92466303 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84010865 |
| 23 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.78189436 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75935494 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72444957 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65644677 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65305723 |
| 28 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64111267 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63378039 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.61801569 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60616739 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60264730 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.57962270 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49541925 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49131957 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48687848 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47879031 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36569119 |
| 39 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35344305 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32898366 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30325435 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27565711 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.25398485 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21680915 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19218444 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17430002 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15270291 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12263523 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05898202 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02857980 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02517681 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01080597 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97807472 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87345303 |
| 55 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86712326 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85822916 |
| 57 | * Lysine degradation_Homo sapiens_hsa00310 | 0.77100119 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73642282 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72020288 |
| 60 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69249101 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66331237 |
| 62 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64219264 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61803243 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60212348 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56364966 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50993105 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48296447 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45249822 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44063480 |
| 70 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42931336 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.42732787 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36945339 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.33059482 |
| 74 | Tight junction_Homo sapiens_hsa04530 | 0.30806202 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30253046 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29277606 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26895645 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24627720 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24353098 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22923028 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.22764553 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.20004259 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.19465282 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18330569 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.17790667 |
| 86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17233257 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11378427 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.10975977 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08839587 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.06247662 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05680144 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00830170 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | -0.1827052 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1753160 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1593541 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1568116 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1547348 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1527887 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.1194995 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1084793 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1042666 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | -0.1008038 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0830789 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0797574 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0787760 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0772215 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0705821 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0681442 |
| 109 | Lysosome_Homo sapiens_hsa04142 | -0.0677899 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0639457 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0359886 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0072134 |

